Eli Lilly invests $450M in North Carolina plant for diabetes drugs

Eli Lilly will invest $450 million in its Research Triangle Park, North Carolina manufacturing plant to expand filling, device assembly and packaging capacity for diabetes drugs Mounjaro and Trulicity. The investment aims to double production by end of 2023 and add 100 jobs. The new phase will be completed in 2027.

“The investment in the Research Triangle Park plant will expand filling, device assembly and packaging capacity to help the Indiana-based drugmaker double production of the injectable drugs by the end of 2023.”manufacturingdive.com

• 1 source
• manufacturingdive.comLilly to boost diabetes drug production with $450M factory investment | Manufacturing DiveJonathan GardnerFeb 1, 2023

Summarized from public sources; check the original articles before acting on it.